SYNAPSE Trademark

Trademark Overview

On Friday, February 18, 2022, a trademark application was filed for SYNAPSE with the United States Patent and Trademark Office. The USPTO has given the SYNAPSE trademark a serial number of 79339845. The federal status of this trademark filing is REGISTERED as of Tuesday, May 14, 2024. This trademark is owned by cliniphar Ltd.. The SYNAPSE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Provision of an online marketplace for buyers and sellers of goods and services; provision of an online marketplace for buyers and sellers of pharmaceuticals; providing information concerning sale of goods and procurement of contracts for the purchase and sale of goods on Internet websites; providing information concerning sale of pharmaceuticals and procurement of contracts for the purchase and sale of pharmaceuticals on Internet websites; providing financial forecasting information concerning estimated sales of pharmaceuticals on Internet websites; retail and wholesale store services featuring pharmaceutical preparations; online retail and wholesale store services featuring pharmaceutical preparations; commercial administration of the licensing of the goods and services of others; commercial administration of the licensing of the pharmaceuticals of others
synapse

General Information

Serial Number79339845
Word MarkSYNAPSE
Filing DateFriday, February 18, 2022
Status700 - REGISTERED
Status DateTuesday, May 14, 2024
Registration Number7383158
Registration DateTuesday, May 14, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2024

Trademark Statements

Goods and ServicesProvision of an online marketplace for buyers and sellers of goods and services; provision of an online marketplace for buyers and sellers of pharmaceuticals; providing information concerning sale of goods and procurement of contracts for the purchase and sale of goods on Internet websites; providing information concerning sale of pharmaceuticals and procurement of contracts for the purchase and sale of pharmaceuticals on Internet websites; providing financial forecasting information concerning estimated sales of pharmaceuticals on Internet websites; retail and wholesale store services featuring pharmaceutical preparations; online retail and wholesale store services featuring pharmaceutical preparations; commercial administration of the licensing of the goods and services of others; commercial administration of the licensing of the pharmaceuticals of others

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party Namecliniphar Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party Namecliniphar Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party Namecliniphar Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Thursday, May 5, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 10, 2022APPLICATION FILING RECEIPT MAILED
Monday, December 5, 2022ASSIGNED TO EXAMINER
Saturday, December 10, 2022NON-FINAL ACTION WRITTEN
Sunday, December 11, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, January 7, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, February 4, 2023REFUSAL PROCESSED BY MPU
Saturday, February 4, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 28, 2023REFUSAL PROCESSED BY IB
Thursday, July 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 19, 2023FINAL REFUSAL WRITTEN
Wednesday, July 19, 2023FINAL REFUSAL E-MAILED
Wednesday, July 19, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 19, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, July 21, 2023ACTION CONTINUING A FINAL - COMPLETED
Friday, July 21, 2023CONTINUATION OF FINAL REFUSAL E-MAILED
Friday, July 21, 2023NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Wednesday, October 11, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, October 11, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, October 31, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Saturday, January 20, 2024EXAMINERS AMENDMENT -WRITTEN
Saturday, January 20, 2024EXAMINERS AMENDMENT E-MAILED
Saturday, January 20, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, January 20, 2024EXAMINER'S AMENDMENT ENTERED
Monday, January 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 7, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, February 26, 2024NOTIFICATION PROCESSED BY IB
Tuesday, February 27, 2024PUBLISHED FOR OPPOSITION
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 14, 2024REGISTERED-PRINCIPAL REGISTER

Related Keywords

synapse pharmaceuticals services sale goods concerning websites providing information internet online